16:42

CALQUENCE® (acalabrutinib) Patient Management & Adherence – Bradley, NP

1:08:05

A Patient Story

22:04

CALQUENCE® (acalabrutinib) ELEVATE-TN, Including 6-Year Median Follow-Up Data – Dr O’ Brien, MD

18:35

CALQUENCE® (acalabrutinib) ACE-CL-001 (ibrutinib-intolerant cohort) – Dr Raval, MD

20:01

CALQUENCE® (acalabrutinib) MAIC of ASCEND and ALPINE – Dr Skarbnik, MD

19:00

CALQUENCE® (acalabrutinib) ELEVATE-RR and ASCEND Data – Dr Ma, MD

17:23

CALQUENCE® (acalabrutinib) Pooled Safety Analysis – Dr Pinilla-lbarz, MD

12:20

CALQUENCE® (acalabrutinib) Perspectives: Dr Alexey Danilov, MD, PhD